IRCT20200909048677N1已完成2 期
Comparing the effectiveness of desloratadine plus montelukast combination therapy and desloratadine monotherapy on quality of life in patients with persistent allergic rhinitis
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Patients with allergic rhinitis who are symptomatic for more than 4 weeks and also more than 4 days a week
- •Existence of persistent allergic rhinitis during the last 2 years
- •Age 18-65 years
排除标准
- •unwillingness to cooperate
- •Severe upper respiratory tract disease during the 6 weeks prior to the study
- •Nasal polyps or deviation of the nasal septum
- •Acute or chronic rhinosinusitis
- •Bronchial asthma
- •Pregnancy or breastfeeding
- •Taking antihistamines during the last 1 month
- •Use of systemic or topical corticosteroids
- •History of allergies to Montelukast or Des Loratadine
研究者
相似试验
进行中（未招募）
不适用
Combined treatment of cinnarizine and iprazochrome in urticaria factitiaEUCTR2012-004002-10-HUDepartment of Dermatology and Allergology, University of Szeged
尚未招募
不适用
Comparative in vivo evaluation of 2 Desloratadine 5 mg Tablet formulations.IRCT20180620040164N40Darou darman Pars Co.24
尚未招募
Unknown
Comparative in vivo evaluation of 2 Desloratadine 5 mg Tablet formulations.IRCT20180620040164N60Actover Pharmaceutical Co.24
尚未招募
Unknown
Comparative in vivo evaluation of 2 Desloratadine 5 mg Tablet formulations.IRCT20180620040164N61Darou darman Arang24
招募中
2 期
The effect of adding Desloratadine to neoadjuvant chemotherapy in patients with breast cancerIRCT20230221057485N1Gorgan University of Medical Sciences104